Riskpilot← Back to searchSign inGet full accessMEDICAL FUTURE AS
ASActiveOrg 921235224Ferstadvegen 109, 5209 OsOther human health activities n.e.c. · NACE 8699Est. 20180 employees
Revenue 2024
NOK 41K
-32% vs 2023
EBITDA margin
-44.3%
-608% vs 2023
Equity ratio
-1057.9%
Financial strength
Net profit 2024
NOK -62K
+82% vs 2023
| Revenue | NOK 41K | -32% |
| EBITDA | NOK -18K | -608% |
| Net profit | NOK -62K | +82% |
| Total assets | NOK 132K | -25% |
| Equity | NOK -1,4M | -2% |
| Employees | 0 | — |
Legal name
MEDICAL FUTURE AS
Org number
921235224
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
13. august 2018
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Botox og restylane injeksjoner, investering og deltakelse i andre selskaper, samt alt som står i forbindelse med dette.
Address
Ferstadvegen 109, 5209 Os
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 758 | 278 | 173 | 60 | 41 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 179 | −30 | −15 | 4 | −18 |
| Depreciation & amort. | −285 | −285 | −247 | −88 | −44 |
| EBIT | −106 | −315 | −262 | −84 | −62 |
| Net financials | −67 | −1 | −1 | 0 | 0 |
| Profit before tax | −173 | −316 | −263 | −84 | −62 |
| Tax | −37 | −69 | −57 | 264 | −0 |
| Net profit | −136 | −247 | −206 | −348 | −62 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 993 | 729 | 556 | 176 | 132 |
| Equity | −561 | −808 | −1 014 | −1 362 | −1 396 |
| Long-term debt | 0 | 0 | 0 | 1 536 | 1 528 |
| Short-term debt | 1 554 | 1 537 | 1 570 | 3 | 0 |
| Total debt | 1 554 | 1 537 | 1 570 | 1 539 | 1 528 |
EBITDA margin
-44.3%
This company
15.8%
Market median
-380% vs market
20202024
Equity ratio
-1057.9%
This company
38.2%
Market median
-2869% vs market
20202024
Return on equity
-6210800.0%
This company
18.4%
Market median
-33754448% vs market
20202024
Net profit margin
-151.4%
This company
8.1%
Market median
-1969% vs market
20202024
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
20202024
Debt / equity
1.09×
This company
0.62×
Market median
-76% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
JW Chief Executive Officer | Chief Executive Officer | 2020 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2023 | |
| Former (1) | ||
| Chairman | 2021 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDICAL FUTURE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| John Widar Mowinckel Storlid | Chief Executive Officer | 0 companies |
| Jon Vangdal Aamaas | Chairman | 0 companies |
| Bjørn Petter Aasheim Johannesen | Chairman | 0 companies |